• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰川崎病患者队列中基于z评分的巨大动脉瘤的消退和并发症

Regression and Complications of z-score-Based Giant Aneurysms in a Dutch Cohort of Kawasaki Disease Patients.

作者信息

Dietz S M, Kuipers I M, Koole J C D, Breur J M P J, Fejzic Z, Frerich S, Dalinghaus M, Roest A A W, Hutten B A, Kuijpers T W

机构信息

Department of Pediatric Hematology, Immunology and Infectious Diseases, Emma Children's Hospital, Academic Medical Centre (AMC), Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

Department of Pediatric Cardiology, Emma Children's Hospital, AMC, Amsterdam, The Netherlands.

出版信息

Pediatr Cardiol. 2017 Apr;38(4):833-839. doi: 10.1007/s00246-017-1590-0. Epub 2017 Feb 24.

DOI:10.1007/s00246-017-1590-0
PMID:28236162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5388726/
Abstract

UNLABELLED

Kawasaki disease (KD) is a pediatric vasculitis. Its main complication is the development of coronary artery aneurysms (CAA), with giant CAA at the end of the spectrum. We evaluated regression and event-free rates in a non-Asian cohort of patients with giant CAA using the current z-scores adjusted for body surface area instead of absolute diameters. KD patients with giant CAA (z-score ≥10) visiting our outpatient clinic between January 1999 and September 2015 were included. Patient characteristics and clinical details were extracted from medical records. Regression was defined as all coronary arteries having a z-score of ≤3. A major adverse event was defined as cardiac death, myocardial infarction, cardiogenic shock, or any coronary intervention. Regression-free and event-free rates were calculated using the Kaplan-Meier method. We included 52 patients with giant CAA of which 45 had been monitored since the acute phase. The 1-, 2-, and 5-year regression-free rates were 0.86, 0.78, and 0.65, respectively. The 5-year, 10-year, and 15-year event-free rates were 0.79, 0.75, and 0.65, respectively. Four children, whose CAA would not have been classified as 'giant' based on absolute diameters instead of z-scores, had experienced an event during follow-up.

CONCLUSION

We found a high percentage of children in whom the lumen of giant CAA completely normalized. Four children not classified as 'giant' based on absolute diameters with z-scores of ≥10 experienced a cardiac event. Hence, the use of z-scores seems to be justified.

摘要

未标注

川崎病(KD)是一种儿科血管炎。其主要并发症是冠状动脉瘤(CAA)的形成,最严重的是巨大冠状动脉瘤。我们使用根据体表面积调整的当前z评分而非绝对直径,评估了非亚洲巨大冠状动脉瘤患者队列中的消退率和无事件发生率。纳入1999年1月至2015年9月期间到我们门诊就诊的巨大冠状动脉瘤(z评分≥10)的KD患者。从病历中提取患者特征和临床细节。消退定义为所有冠状动脉z评分为≤3。主要不良事件定义为心源性死亡、心肌梗死、心源性休克或任何冠状动脉介入治疗。使用Kaplan-Meier方法计算无消退率和无事件发生率。我们纳入了52例巨大冠状动脉瘤患者,其中45例自急性期起接受监测。1年、2年和5年的无消退率分别为0.86、0.78和0.65。5年、10年和15年的无事件发生率分别为0.79、0.75和0.65。4名儿童,若根据绝对直径而非z评分,其冠状动脉瘤不会被归类为“巨大”,在随访期间发生了事件。

结论

我们发现很大比例的巨大冠状动脉瘤患儿管腔完全恢复正常。4名根据绝对直径未被归类为“巨大”但z评分≥10的儿童发生了心脏事件。因此,使用z评分似乎是合理的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6c/5388726/13c5c8f7c114/246_2017_1590_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6c/5388726/db3e41a9253c/246_2017_1590_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6c/5388726/1465fa442d37/246_2017_1590_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6c/5388726/13c5c8f7c114/246_2017_1590_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6c/5388726/db3e41a9253c/246_2017_1590_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6c/5388726/1465fa442d37/246_2017_1590_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6c/5388726/13c5c8f7c114/246_2017_1590_Fig3_HTML.jpg

相似文献

1
Regression and Complications of z-score-Based Giant Aneurysms in a Dutch Cohort of Kawasaki Disease Patients.荷兰川崎病患者队列中基于z评分的巨大动脉瘤的消退和并发症
Pediatr Cardiol. 2017 Apr;38(4):833-839. doi: 10.1007/s00246-017-1590-0. Epub 2017 Feb 24.
2
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.川崎病冠状动脉瘤:美国人群中进展性疾病和不良心脏事件的危险因素。
J Am Heart Assoc. 2016 Sep 15;5(9):e003289. doi: 10.1161/JAHA.116.003289.
3
Outcomes of Kawasaki disease with giant coronary aneurysms: a single-centre study in southwest China.川崎病合并巨大冠状动脉瘤的结局:中国西南部单中心研究。
Cardiol Young. 2020 Jun;30(6):834-839. doi: 10.1017/S1047951120001134. Epub 2020 Jun 8.
4
Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.川崎病患者冠状动脉瘤严重程度与后期冠状动脉事件风险的相关性研究。
JAMA Pediatr. 2018 May 7;172(5):e180030. doi: 10.1001/jamapediatrics.2018.0030.
5
Giant aneurysms: A gender-specific complication of Kawasaki disease?巨大动脉瘤:川崎病的一种性别特异性并发症?
J Cardiol. 2017 Oct;70(4):359-365. doi: 10.1016/j.jjcc.2016.12.014. Epub 2017 Mar 18.
6
Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.川崎病后冠状动脉瘤的中期并发症:来自国际川崎病注册研究。
J Am Heart Assoc. 2020 Aug 4;9(15):e016440. doi: 10.1161/JAHA.119.016440. Epub 2020 Jul 28.
7
Etiology and prognosis of non-Kawasaki disease induced coronary aneurysms in children: a retrospective case series study.儿童非川崎病相关性冠状动脉瘤的病因和预后:一项回顾性病例系列研究。
Eur J Pediatr. 2024 Oct;183(10):4229-4234. doi: 10.1007/s00431-024-05666-5. Epub 2024 Jul 11.
8
Cardiac Events and the Maximum Diameter of Coronary Artery Aneurysms in Kawasaki Disease.川崎病中的心脏事件与冠状动脉瘤最大直径
J Pediatr. 2017 Sep;188:70-74.e1. doi: 10.1016/j.jpeds.2017.05.055. Epub 2017 Jun 26.
9
Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline Scores.北美某中心对川崎病患者冠状动脉瘤的预测:基线评分评估
J Am Heart Assoc. 2017 May 31;6(6):e005378. doi: 10.1161/JAHA.116.005378.
10
[Kawasaki disease in children--9 years experience].[儿童川崎病——9年经验]
Med Wieku Rozwoj. 2005 Apr-Jun;9(2):179-93.

引用本文的文献

1
Kawasaki Disease Diagnosis and Treatment in over 1000 Patients: A Continuum of Dysregulated Inflammatory Responses.1000余例川崎病患者的诊断与治疗:炎症反应失调的连续过程
Biomedicines. 2024 Sep 3;12(9):2014. doi: 10.3390/biomedicines12092014.
2
Practical Workflow for Cardiovascular Assessment and Follow-Up in Kawasaki Disease Based on Expert Opinion.基于专家意见的川崎病心血管评估及随访实用工作流程
Front Pediatr. 2022 Jun 9;10:873421. doi: 10.3389/fped.2022.873421. eCollection 2022.
3
A retrospective cohort study of major adverse cardiac events in children affected by Kawasaki disease with coronary artery aneurysms in Thailand.

本文引用的文献

1
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.川崎病冠状动脉瘤:美国人群中进展性疾病和不良心脏事件的危险因素。
J Am Heart Assoc. 2016 Sep 15;5(9):e003289. doi: 10.1161/JAHA.116.003289.
2
Kawasaki Disease.川崎病。
J Am Coll Cardiol. 2016 Apr 12;67(14):1738-49. doi: 10.1016/j.jacc.2015.12.073.
3
Progressive Coronary Dilatation Predicts Worse Outcome in Kawasaki Disease.冠状动脉进行性扩张预示川崎病的预后更差。
泰国川崎病伴冠状动脉瘤患儿主要不良心脏事件的回顾性队列研究。
PLoS One. 2022 Jan 27;17(1):e0263060. doi: 10.1371/journal.pone.0263060. eCollection 2022.
4
CT Angiography or Cardiac MRI for Detection of Coronary Artery Aneurysms in Kawasaki Disease.CT血管造影或心脏MRI用于检测川崎病中的冠状动脉瘤
Front Pediatr. 2021 Feb 4;9:630462. doi: 10.3389/fped.2021.630462. eCollection 2021.
5
Complete Regression of Giant Aneurysms in an Infant with Delayed Diagnosis and Refractory Kawasaki Disease via Combination Anticytokine Therapy: Case Report and Review of Similar Cases.通过联合抗细胞因子疗法使一名诊断延迟且患有难治性川崎病的婴儿巨大动脉瘤完全消退:病例报告及类似病例回顾
Case Rep Rheumatol. 2020 Mar 28;2020:6249013. doi: 10.1155/2020/6249013. eCollection 2020.
6
Coronary artery assessment in Kawasaki disease with dual-source CT angiography to uncover vascular pathology.应用双源 CT 血管造影术评估川崎病冠状动脉,以揭示血管病理学改变。
Eur Radiol. 2020 Jan;30(1):432-441. doi: 10.1007/s00330-019-06367-6. Epub 2019 Aug 19.
J Pediatr. 2016 Apr;171:78-82.e1. doi: 10.1016/j.jpeds.2015.12.076. Epub 2016 Feb 4.
4
Cardiovascular imaging in children and adults following Kawasaki disease.川崎病后儿童和成人的心血管成像
Insights Imaging. 2015 Dec;6(6):697-705. doi: 10.1007/s13244-015-0422-0. Epub 2015 Jul 27.
5
Coronary Wall Structural Changes in Patients With Kawasaki Disease: New Insights From Optical Coherence Tomography (OCT).川崎病患者冠状动脉壁结构变化:光学相干断层扫描(OCT)的新见解
J Am Heart Assoc. 2015 May 19;4(5):e001939. doi: 10.1161/JAHA.115.001939.
6
Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy.1073 例川崎病患者静脉用γ-免疫球蛋白治疗与未治疗的急性期和晚期冠状动脉结局。
Arch Dis Child. 2015 Jun;100(6):542-7. doi: 10.1136/archdischild-2014-306427. Epub 2015 Jan 6.
7
Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version.川崎病心血管后遗症的诊断与管理指南(2013年日本循环学会版)。摘要版
Circ J. 2014;78(10):2521-62. doi: 10.1253/circj.cj-66-0096. Epub 2014 Sep 22.
8
A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease.川崎病致巨大动脉瘤患者 30 年结局的调查。
Am Heart J. 2014 Feb;167(2):249-58. doi: 10.1016/j.ahj.2013.10.025. Epub 2013 Nov 6.
9
Radiation dose reduction in pediatric cardiac computed tomography: experience from a tertiary medical center.儿科心脏计算机断层扫描中的辐射剂量降低:来自一家三级医疗中心的经验。
Pediatr Cardiol. 2014 Jan;35(1):171-9. doi: 10.1007/s00246-013-0758-5. Epub 2013 Jul 20.
10
Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease.仅基于川崎病后冠状动脉z评分对冠状动脉异常进行的改良分类。
Pediatr Cardiol. 2010 Feb;31(2):242-9. doi: 10.1007/s00246-009-9599-7. Epub 2009 Dec 19.